化疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00007601
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

预计化疗市场在 2023 年至 2031 年期间的复合年增长率为 8.2%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告按适应症(结直肠癌、乳腺癌、肺癌、胃癌、卵巢癌、淋巴瘤、前列腺癌、白血病等)、药物类别(拓扑异构酶抑制剂、有丝分裂抑制剂、抗肿瘤抗生素、烷化剂等)、给药途径(皮下、肌肉内、静脉内、囊内、脑室内/鞘内、局部、口服、腹膜内等)进行细分。报告进一步根据最终用户(医院和诊所、专科中心、其他)进行分析。全球分析进一步细分为区域和主要国家。报告以美元为单位提供上述分析和细分的价值。

报告目的

The Insight Partners 的《化疗市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

化疗市场细分

 

指征

  • 结直肠癌
  • 乳腺癌
  • 肺癌
  • 胃癌
  • 卵巢癌
  • 淋巴瘤
  • 前列腺癌
  • 白血病
  • 其他的

药物类别

  • 拓扑异构酶抑制剂
  • 有丝分裂抑制剂
  • 抗肿瘤抗生素
  • 烷化剂
  • 其他的

给药途径

  • 皮下
  • 肌肉内
  • 静脉
  • 囊内
  • 脑室内/鞘内
  • 主题
  • 口服
  • 腹腔内
  • 其他的

最终用户

  • 医院和诊所
  • 专业中心
  • 其他的

最终用户

  • 医院和诊所
  • 专业中心
  • 其他的

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

化疗市场:战略洞察

Chemotherapy Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

化疗市场增长动力

  • 癌症发病率上升:推动化疗市场的主要因素之一是全球癌症发病率上升。世界卫生组织估计,未来二十年内癌症新发病例将增加 60%。到 2030 年,新发病例数量将达到每年 2500 万,从而增加化疗治疗需求,从而扩大市场。
  • 靶向治疗的进展:靶向治疗是针对癌细胞而不伤害非癌细胞的化疗。靶向治疗的进展因此创造了更有效但毒性更小的化疗,并被更广泛地采用。靶向治疗是肿瘤学家的突破;因此,靶向或精准医疗必须做得更好,药物更均质,这可能导致患者疗效更均匀。随着研究的不断进展,可能会发现更有效、更有针对性的化疗药物。
  • 联合疗法的应用日益广泛:联合疗法是指采用多种化疗药物或疗法,与单一化疗药物或疗法相比,其疗效更佳。联合疗法的这种发展趋势为患者提供了多种更有效的治疗选择,从而推动了该市场的需求。近年来,人们已经意识到,患者使用联合疗法可以改善治疗效果,减少副作用。

化疗市场未来趋势

  • 免疫疗法需求不断增长:免疫疗法是一种癌症治疗方法,旨在帮助控制癌细胞通过人体免疫系统的扩散。针对不同类型癌症的免疫疗法需求不断增长是该市场的主要增长因素。肺癌、乳腺癌和结肠癌是有望治愈的几种癌症之一。更多研究将表明,未来的治疗方法将更加有效,从而进一步促进市场增长。
  • 数字疗法增强了患者护理:数字疗法是一种基于技术的治疗方法,已成为帮助患者管理化疗计划的用户友好型方法。随着时间的推移,数字疗法逐渐成为增强患者护理效果和减少治疗副作用的工具。数字疗法可以说是患者管理化疗治疗最方便、最简单的方式。随着医疗服务提供商对数字疗法的认识不断提高,其采用率必将提高,这反过来将促进市场增长。
  • 远程医疗很可能成为化疗交付的一个增长趋势:根据最新趋势,远程医疗正在改变化疗管理模式。远程医疗通过进行远程咨询和监控患者的治疗过程,可以改善患者的治疗效果并降低医疗成本。远程医疗正在改变向患者提供的医疗服务的面貌。因此,当远程医疗成为主流交付方式时,更有效、更高效的交付模式将会出现,从而推动市场进一步增长。

化疗市场机会

  • 将现有疗法开发为新适应症:虽然化疗仅针对一小部分癌症,但有大量证据表明,大多数化疗对其他癌症也同样有效。进一步的适应症可能代表市场的增长领域。扩大已上市疗法的适应症将增加进一步市场增长的可能性,因为更多的患者可以获得适当的治疗。未来研究和新用途的发现有望扩大现有疗法的适应症,这将导致此类疗法的适应症进一步扩大,并进一步扩大市场增长。
  • 新型治疗方式:新型治疗方式(例如基于纳米技术的治疗)可能为进一步扩大市场提供新的途径。此类基于纳米技术的治疗有望改善患者的治疗效果并减少治疗本身的副作用。新型治疗方式的进一步发展只会随着时间的推移而增加,我们可能会看到更多新颖的解决方案出现,从而推动市场朝这个方向增长。
  • 更加关注患者报告结果:最近,化疗疗效越来越重要,患者报告结果就是其中之一。关注这些结果将有助于医疗专业人员了解患者需要什么、需要什么以及患者更喜欢什么。患者报告结果对改善患者护理大有裨益,这在很大程度上是基于对患者需求和偏好的更好理解。未来几年,随着医疗服务提供者越来越意识到患者报告结果的重要性,人们将更加关注该领域,并考虑开展更多的研究和开发活动。

 

化疗市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响化疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的化疗市场细分和地理位置。

Chemotherapy Market
  • 获取化疗市场的区域特定数据

化疗市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)8.2%
史料2021-2022
预测期2024-2031
涵盖的领域按适应症
  • 结直肠癌
  • 乳腺癌
  • 肺癌
  • 胃癌
  • 卵巢癌
  • 淋巴瘤
  • 前列腺癌
  • 白血病
  • 其他的
按药物类别
  • 拓扑异构酶抑制剂
  • 有丝分裂抑制剂
  • 抗肿瘤抗生素
  • 烷化剂
  • 其他的
按给药途径
  • 皮下
  • 肌肉内
  • 静脉
  • 囊内
  • 脑室内/鞘内
  • 主题
  • 口服
  • 腹腔内
  • 其他的
按最终用户
  • 医院和诊所
  • 专业中心
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 百时美施贵宝公司
  • 新基公司
  • 礼来公司
  • F. 霍夫曼-罗氏有限公司
  • 葛兰素史克公司
  • 强生服务公司
  • 默克公司
  • 诺华公司
  • 辉瑞公司

 

化疗市场参与者密度:了解其对业务动态的影响

化疗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在化疗市场运营的主要公司有:

  1. 百时美施贵宝公司
  2. 新基公司
  3. 礼来公司
  4. F. 霍夫曼-罗氏有限公司
  5. 葛兰素史克公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Chemotherapy Market

 

  • 了解化疗市场顶级关键参与者概况

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖化疗市场的产品、服务、类型和最终用户的分析,提供整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,化疗市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the chemotherapy market?

The chemotherapy market is estimated to grow with a CAGR of 8.2% from 2023 to 2031

Which are the leading players operating in the chemotherapy market?

The chemotherapy market majorly consists of players such as Bristol-Myers Squibb Company, Celgene Corporation, Eli Lilly and Company among others.

Which region is expected to witness the fastest growth rate by 2031?

Asia-Pacific region is likely to witness the fastest growth rate during the forecast period

What are the driving factors impacting the chemotherapy market?

The market drivers include the increasing prevalence of cancer and rising geriatric population, which are driving the chemotherapy market.

What are the future trends of the chemotherapy market?

Development of immunotherapies is likely to remain the key trend during the forecast period.

Which region dominated the chemotherapy market in 2023?

North America dominated the chemotherapy market in 2023

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Bristol-Myers Squibb Company
2. Celgene Corporation
3. Eli Lilly and Company
4. F. Hoffmann-La Roche Ltd
5. GlaxoSmithKline PLC
6. Johnson & Johnson Services Inc
7. Merck & Co. Inc.
8. Novartis AG
9. Pfizer Inc.
10. Sanofi S.A.

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.